查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1577507

心臟缺陷閉合裝置的全球市場

Heart Defect Closure Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球心臟缺陷閉合裝置市場預計將達到 66 億美元

2023 年全球心臟缺陷閉合設備市場估計為 27 億美元，預計到 2030 年將達到 66 億美元，2023-2030 年分析期間複合年成長率為 13.5%。左心耳 (LAA) 封堵器是本報告分析的細分市場之一，預計複合年成長率為 14.4%，到分析期結束時將達到 35 億美元。在分析期間，先天性心臟病 (CHD) 封堵器市場的複合年成長率預計為 12.9%。

美國市場預計將達到7.427億美元，中國預計複合年成長率為18.2%。

預計 2023 年美國心臟缺陷閉合設備市場規模將達 7.427 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達15億美元，2023-2030年分析期間複合年成長率為18.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 10.0% 和 11.8%。在歐洲，德國預計複合年成長率為 10.7%。

全球心臟缺陷封堵器市場—主要趨勢與促進因素總結

為什麼心臟缺陷閉合裝置對於心血管健康管理至關重要？

心臟缺陷閉合裝置是治療結構性心臟異常的重要工具，提供了一種微創解決方案，可顯著降低先天性和後天性心臟缺陷相關的風險。這些設備主要用於治療心房中膈缺損症(ASD)、卵圓孔未閉合(PFO) 和室間隔缺損 (VSD) 等疾病，如果不及時治療，所有這些疾病都會損害正常的心臟功能，從而導致併發症。如中風、心臟衰竭和心律不整。傳統上，此類缺陷需要進行心臟直視手術，但心臟直視手術併發症風險很高，並且需要很長的恢復時間。然而，心臟缺陷閉合裝置提供了一種侵入性較小的替代方案，允許心臟科醫師使用基於導管的手術來閉合此類缺陷。這種方法不僅可以最大限度地減少創傷，而且可以縮短恢復時間，使其成為兒童和成人患者的首選。這些設備能夠提供安全有效的治療結果，從而改變了治療格局，減少了對複雜手術介入的需求，並使心臟缺陷管理變得更加容易。因此，這些設備已成為現代心血管治療的基石，並且不斷進步，擴大其適應症並提高其手術效率。

塑造心臟缺陷封堵器市場的主要趨勢和技術進步是什麼？

由於不斷變化的臨床需求、技術創新以及對以患者為中心的護理的關注，心臟缺陷閉合設備市場正在快速發展。最顯著的趨勢之一是下一代生物可吸收裝置的開發。該裝置提供臨時支撐，不需要永久植入，因為一旦缺損閉合，它就會逐漸溶解。這種生物可吸收裝置可減少長期併發症，例如裝置腐蝕和對未來手術的干擾，從而提高患者安全和治療效果。另一個重要趨勢是儀器的小型化。這使得能夠治療較小的缺陷並擴大其在新生兒和兒科患者中的使用。這些小型、靈活的器械旨在更輕鬆地處理複雜的解剖結構，降低手術風險並提高年輕患者缺損閉合的成功率。此外，3D 超音波心動圖和即時 MRI 等先進成像技術的整合透過在設備就位時提供心臟結構的詳細可視化來提高手術的精確度。這對於複雜情況尤其有利，因為精確定位對於獲得最佳結果非常重要。此外，人們越來越重視混合手術，結合基於導管的技術和外科技術來治療多方面或高風險的缺陷。這種混合方法可以實現量身定做的治療策略，並為以前被認為無法手術的患者提供新的可能性。這些趨勢和創新不僅擴大了心臟缺陷閉合裝置的功能，而且正在重塑先天性和結構性心臟疾病治療的臨床方法。

技術創新如何提高心臟缺陷閉合裝置的性能和安全性？

技術創新在提高心臟缺損閉合裝置的性能、安全性和多功能性方面發揮著至關重要的作用，解決了與傳統方法相關的一些長期挑戰。最重要的進步之一是鎳鈦合金等新材料的使用。鎳鈦諾提供卓越的柔韌性和形狀記憶，使其能夠更有效地貼合心臟的輪廓。鎳鈦諾的生物相容性也最大限度地降低了副作用的風險，並促進與心臟組織的整合。此外，正在探索使用生物可吸收聚合物來提供臨時支架並創建隨著時間的推移而無害分解的裝置，以減少長期併發症的風險和二次手術的需要，數量正在增加。另一個突破是採用塗層技術，提高了設備的血液相容性，降低了血栓形成的風險，並減少了長期抗凝血治療的需要。此外，即時影像整合，例如血管內超音波(IVUS) 和 3D 測繪系統的使用，可顯著提高臨床醫生放置設備的精度，確保準確放置並最大程度地消除程序錯誤。遠端控制和機器人輔助系統的發展進一步提高了可操作性和穩定性，使手術更加安全，特別是在複雜的解剖環境中。這些進步不僅使手術變得更安全、更有效，而且為最困難病例的廣泛採用鋪平了道路，並改善了先天性和結構性心臟疾病患者的整體治療。

是什麼推動了心臟閉合裝置市場的成長？

心臟缺陷閉合裝置市場的成長是由幾個因素推動的，這些因素主要受先天性心臟缺陷盛行率的增加、微創技術的進步以及對早期療育選擇的認知不斷增強的影響。主要成長要素之一是全球先天性心臟異常發生率的上升，這增加了對安全有效治療方案的需求。診斷技術的進步，例如在產前診斷中使用高解析度影像，可以及早發現心臟異常，從而增加適合接受閉合手術的患者數量。此外，人們越來越傾向於微創心臟治療，與傳統的心臟直視手術相比，微創心臟治療有望縮短恢復時間，降低併發症發生率並提高患者滿意度，這將顯著推動市場成長。另一個重要因素是兒科族群擴大採用基於導管的手術。這是由於年輕患者需要安全、有效且侵入性較小的解決方案而推動的。專用兒科設備的日益普及為新生兒和嬰幼兒患者開闢了新的治療可能性，這些患者通常面臨獨特的解剖學和臨床挑戰。此外，新興市場醫療保健支出的增加和心臟專科醫療中心的擴張正在為採用這些先進治療設備創造新的機會。隨著具有增強安全性和擴大適應症的新設備被引入市場，主要市場參與企業對研發的持續投資也有助於成長。心臟缺陷閉合設備在更廣泛的心血管設備產業中迅速擴張，有利的報銷政策和監管支持進一步推動了北美和歐洲等地區的採用。這些因素，再加上對以患者為中心的護理和長期結果的日益關注，確保心臟缺陷閉合設備始終處於創新心血管健康管理的前沿，並推動市場向前發展。

受訪企業範例（總合36 家知名企業）

  • Abbott Cardiovascular
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Encore Medical
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Lifetech Scientific Corporation
  • Meril Life Sciences Pvt., Ltd.
  • MicroPort Scientific Corporation
  • Occlutech US LLC
  • Sahajanand Medical Technologies Pvt., Ltd.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP24300

Global Heart Defect Closure Devices Market to Reach US$6.6 Billion by 2030

The global market for Heart Defect Closure Devices estimated at US$2.7 Billion in the year 2023, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Left Atrial Appendage (LAA) Closure Device, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Congenital Heart Defect (CHD) Closure Device segment is estimated at 12.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$742.7 Million While China is Forecast to Grow at 18.2% CAGR

The Heart Defect Closure Devices market in the U.S. is estimated at US$742.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 18.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global Heart Defect Closure Devices Market - Key Trends and Drivers Summarized

Why Are Heart Defect Closure Devices Crucial in Cardiovascular Health Management?

Heart defect closure devices are critical tools in the treatment of structural heart anomalies, providing minimally invasive solutions that significantly reduce the risks associated with congenital and acquired heart defects. These devices are primarily used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and ventricular septal defects (VSD), all of which can impair normal cardiac function and lead to complications like stroke, heart failure, and arrhythmias if left untreated. Traditionally, such defects required open-heart surgery, which carries a high risk of complications and a prolonged recovery period. Heart defect closure devices, however, offer a less invasive alternative by allowing cardiologists to seal these defects using catheter-based procedures. This approach not only minimizes trauma but also enables faster recovery times, making it a preferred option for both pediatric and adult patients. The ability of these devices to deliver safe and effective outcomes has revolutionized the treatment landscape, reducing the need for complex surgical interventions and making heart defect management more accessible. As a result, these devices have become a cornerstone of modern cardiovascular care, with ongoing advancements aiming to expand their indications and improve procedural efficiency.

What Are the Key Trends and Technological Advancements Shaping the Heart Defect Closure Device Market?

The heart defect closure device market is witnessing rapid advancements, driven by a combination of evolving clinical needs, technological innovations, and increased focus on patient-centric care. One of the most prominent trends is the development of next-generation, bioresorbable devices that offer temporary support and gradually dissolve after the defect is closed, eliminating the need for permanent implants. These bioresorbable devices reduce long-term complications, such as device erosion and interference with future procedures, thereby enhancing patient safety and outcomes. Another significant trend is the miniaturization of devices, which is enabling the treatment of smaller defects and expanding their use in neonatal and pediatric patients. These smaller, more flexible devices are designed to navigate complex anatomies with greater ease, reducing procedural risks and improving the success rate of defect closure in younger populations. In addition, the integration of advanced imaging technologies, such as 3D echocardiography and real-time MRI, is enhancing procedural precision by providing detailed visualizations of the heart’s structure during device placement. This is particularly beneficial for complex cases where precise positioning is critical for optimal outcomes. Furthermore, there is a growing emphasis on hybrid procedures that combine catheter-based and surgical techniques to treat multi-faceted or high-risk defects. These hybrid approaches allow for tailored treatment strategies, offering new possibilities for patients who were previously considered inoperable. Collectively, these trends and innovations are not only expanding the capabilities of heart defect closure devices but are also reshaping the clinical approach to congenital and structural heart defect management.

How Are Technological Innovations Improving the Performance and Safety of Heart Defect Closure Devices?

Technological innovations are playing a pivotal role in enhancing the performance, safety, and versatility of heart defect closure devices, addressing some of the longstanding challenges associated with traditional approaches. One of the most significant advancements is the use of new materials, such as nitinol, which offer superior flexibility and shape memory, allowing devices to conform more effectively to the contours of the heart. Nitinol’s biocompatibility also minimizes the risk of adverse reactions and promotes better integration with the cardiac tissue. Additionally, bioresorbable polymers are being increasingly utilized to create devices that provide temporary scaffolding and then degrade harmlessly over time, reducing the risk of long-term complications and the need for secondary procedures. Another breakthrough is the incorporation of coating technologies that enhance the hemocompatibility of devices, reducing the risk of thrombus formation and the need for long-term anticoagulation therapy. Moreover, real-time imaging integration, such as the use of intravascular ultrasound (IVUS) and 3D mapping systems, is providing clinicians with unparalleled accuracy during device deployment, ensuring precise placement and minimizing procedural errors. The development of remote-controlled and robotic-assisted systems is further improving procedural safety by offering enhanced maneuverability and stability, especially in complex anatomical settings. These advancements are not only making heart defect closure devices safer and more effective but are also paving the way for broader adoption in challenging cases, thereby improving the overall treatment landscape for patients with congenital and structural heart defects.

What Is Driving the Growth of the Heart Defect Closure Device Market?

The growth in the heart defect closure device market is driven by several factors, primarily influenced by increasing prevalence of congenital heart defects, advancements in minimally invasive technologies, and growing awareness of early intervention options. One of the main growth drivers is the rising incidence of congenital heart anomalies globally, which is leading to greater demand for safe and effective treatment options. Advances in diagnostic techniques, such as the use of high-resolution imaging in prenatal care, are enabling earlier detection of heart defects, thereby increasing the number of patients eligible for closure procedures. Additionally, the ongoing shift towards minimally invasive cardiac interventions is significantly boosting market growth, as these procedures offer reduced recovery times, lower complication rates, and improved patient satisfaction compared to traditional open-heart surgeries. Another critical factor is the growing adoption of catheter-based techniques in pediatric populations, driven by the need for safe, effective, and less invasive solutions for younger patients. The increasing availability of specialized pediatric devices is opening up new treatment possibilities for neonatal and infant patients, who often present unique anatomical and clinical challenges. Furthermore, rising healthcare expenditure and the expansion of specialized cardiac care centers in emerging markets are creating new opportunities for the adoption of these advanced therapeutic devices. The continuous investment in research and development by key market players is also contributing to the growth, as new devices with enhanced safety features and broader indications enter the market. Favorable reimbursement policies and regulatory support in regions like North America and Europe are further driving adoption, making heart defect closure devices a rapidly expanding segment within the broader cardiovascular device industry. These factors, combined with the growing focus on patient-centric care and long-term outcomes, are propelling the market forward, ensuring that heart defect closure devices remain at the forefront of innovative cardiovascular health management.

Select Competitors (Total 36 Featured) -

  • Abbott Cardiovascular
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Encore Medical
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Lifetech Scientific Corporation
  • Meril Life Sciences Pvt., Ltd.
  • MicroPort Scientific Corporation
  • Occlutech US LLC
  • Sahajanand Medical Technologies Pvt., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Heart Defect Closure Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Congenital Heart Defects Drives Demand for Heart Defect Closure Devices
    • Here's the Story: How Growing Adoption of Minimally Invasive Procedures Expands the Addressable Market for Non-Surgical Closure Devices
    • Increasing Focus on Pediatric Cardiac Care Propels Market Growth for Advanced Closure Solutions
    • Advancements in Device Design and Materials Strengthen the Business Case for Next-Generation Heart Defect Closure Devices
    • Here's How the Shift Towards Catheter-Based Interventions Generates Opportunities for Transcatheter Closure Devices
    • Expansion of Hybrid Cardiac Procedures Transforms Market Dynamics by Offering Combined Surgical and Transcatheter Solutions
    • Emphasis on Reducing Recovery Time and Post-Operative Complications Sustains Demand for Minimally Invasive Devices
    • Growing Use of Imaging Technologies Enhances Precision in Device Placement and Improves Surgical Outcomes
    • Here's How Rising Adoption of Wearable Health Monitors Spurs Growth in Demand for Early Intervention Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Defect Closure Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Defect Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Left Atrial Appendage (LAA) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Left Atrial Appendage (LAA) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Congenital Heart Defect (CHD) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Congenital Heart Defect (CHD) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Congenital Heart Defect (CHD) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Patent Foramen Ovale (PFO) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Patent Foramen Ovale (PFO) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Patent Foramen Ovale (PFO) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • JAPAN
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • CHINA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • EUROPE
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Heart Defect Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • FRANCE
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • GERMANY
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Heart Defect Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • INDIA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Heart Defect Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Heart Defect Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • AFRICA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030

IV. COMPETITION